FDA Adverse Event Injury Summary report: N

G7 54-F PPS LIMITED ACETABULAR SHELL

MDR report key: 6908723 · Received October 2, 2017

Report

Report Number
0001825034-2017-07705
Event Type
Injury
Date Received
October 2, 2017
Date of Event
May 18, 2017
Report Date
January 5, 2018
Manufacturer
ZIMMER BIOMET, INC.
Product Code
PBI
PMA / PMN Number
PK121874
Removal / Correction Number
N/A
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
SW
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

(B)(6). MULTIPLE MDR¿S WERE SUBMITTED FOR THIS EVENT. PLEASE SEE REPORTS: 0001825034 - 2017 - 07704, 0001825034 - 2017 - 07705. CONCOMITANT- 192013 ECHO POR FMRL NC 13X145MM LOT# 751010; 010000664 G7 PPS LTD ACET SHELL 54F LOT# 3790818; 650-1161 DELTA CER FEM HD 32/+3MM T1 LOT# 2016021417; 110003619 BIOLOX DELTA CER LNR 32MM F LOT# 3230050. (B)(6). THE INVESTIGATION IS IN PROCESS. ONCE THE INVESTIGATION HAS BEEN COMPLETED, A FOLLOW-UP MDR WILL BE SUBMITTED. DEVICE REMAINS IMPLANTED.

Additional Manufacturer Narrative · 1

THIS FOLLOW-UP REPORT IS BEING SUBMITTED TO RELAY ADDITIONAL INFORMATION. REPORTED EVENT WAS ABLE TO BE CONFIRMED VIA CLINICAL OPERATIVE NOTES. DEVICE HISTORY RECORD (DHR) WAS REVIEWED AND NO DISCREPANCIES RELEVANT TO THE REPORTED EVENT WERE FOUND. REVIEW OF COMPLAINT HISTORY DETERMINED THAT NO FURTHER ACTION IS REQUIRED. ROOT CAUSE WAS UNABLE TO BE DETERMINED. IF ANY FURTHER INFORMATION IS FOUND WHICH WOULD CHANGE OR ALTER ANY CONCLUSIONS OR INFORMATION, A SUPPLEMENTAL WILL BE FILED ACCORDINGLY. ZIMMER BIOMET WILL CONTINUE TO MONITOR FOR TRENDS.

Description of Event or Problem · 1

IT WAS REPORTED THAT THE PATIENT SUFFERED FASCIA RUPTURE. THE PATIENT SUBSEQUENTLY UNDERWENT A PROCEDURE FOR SUTURE OF FASCIA. NO FURTHER INFORMATION HAS BEEN MADE AVAILABLE AT THIS TIME.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
688217 G7 54-F PPS LIMITED ACETABULAR SHELL PROSTHESIS, HIP PBI ZIMMER BIOMET, INC. N/A 3790818

Patients

Seq Age Sex Outcome Treatment
1 53 YR Hospitalization| R